Leukemia Drug's bone risk under the microscope

NCT ID NCT06367725

Recruiting now Knowledge-focused Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how the steroid dexamethasone, used to treat childhood acute lymphoblastic leukemia, affects bone density and the nervous system. Researchers will measure drug levels in blood and spinal fluid, and track bone loss and nerve-related side effects. The goal is to find ways to reduce these side effects in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dexamethasone
What this could lead to: If successful, this study could help doctors understand how to adjust dexamethasone doses to reduce bone loss and nerve side effects in children with leukemia.
What could go wrong: This is an observational study, not a treatment trial, so it will not directly test a new therapy. Results may not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lymphoblastic leukemia Precursor Cell Lymphoblastic Leukemia-Lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE LYMPHOBLASTIC LEUKEMIA

Contacts and locations

Locations

Department of Paediatrics and Adolescent Medicine, Aalborg University Hospital
RECRUITING

Aalborg, Aalborg, 9000, Denmark
Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital
RECRUITING

Aarhus N, Aarhus N, 8200, Denmark
Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet
RECRUITING

Copenhagen, København Ø, 2100, Denmark
Department of Paediatrics and Adolescent Medicine, Odense University Hospital
RECRUITING

Odense, Odense C, 5000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.